Orphan Drug Market Access: Payer Insights on the Present and Future is a report that examines the regulation, pricing, reimbursement, players and stakeholder/payer interests that are shaping the current and future direction of the orphan drug sector. This report offers insights from US and European healthcare payers and includes illustrative case studies that highlight key aspects of the orphan drug market. Available for purchase here. (Source: FirstWord, October 2014).
You are here: / / Will The Majority Of Future Drugs Meet Orphan Drug Criteria?